Cargando…
Impact of Cefazolin Shortage on Clinical Outcomes of Adult Patients with Bacteremia Caused by Methicillin-Susceptible Staphylococcus aureus in a Tertiary Care University Hospital
Cefazolin is an essential antibiotic used for treating bacteremia; in particular, it is recommended as a first-line agent for infections caused by methicillin-susceptible Staphylococcus aureus (MSSA). In March 2019, problems with a major antibiotic supplier caused a critical shortage of cefazolin in...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532967/ https://www.ncbi.nlm.nih.gov/pubmed/34680827 http://dx.doi.org/10.3390/antibiotics10101247 |
_version_ | 1784587197772464128 |
---|---|
author | Uda, Atsushi Onuma, Kenichiro Shigemura, Katsumi Kitagawa, Koichi Yan, Yonmin Osawa, Kayo Yano, Ikuko Miyara, Takayuki |
author_facet | Uda, Atsushi Onuma, Kenichiro Shigemura, Katsumi Kitagawa, Koichi Yan, Yonmin Osawa, Kayo Yano, Ikuko Miyara, Takayuki |
author_sort | Uda, Atsushi |
collection | PubMed |
description | Cefazolin is an essential antibiotic used for treating bacteremia; in particular, it is recommended as a first-line agent for infections caused by methicillin-susceptible Staphylococcus aureus (MSSA). In March 2019, problems with a major antibiotic supplier caused a critical shortage of cefazolin in Japan; however, the impact of the cefazolin shortage on clinical outcomes remains unknown. This study aimed to evaluate the effect of the cefazolin shortage in patients with MSSA bacteremia. Data from 75 patients were compared between the pre-shortage (March 2018–January 2019, n = 39) and post-shortage (March 2019–January 2020, n = 36) periods. There were no significant differences in the demographic characteristics between the two groups, and the cefazolin shortage did not worsen clinical outcomes such as adverse drug reactions, treatment failure, and 30-day mortality. In the post-shortage group, ampicillin/sulbactam and benzylpenicillin were more frequently administered as alternative antibiotics for empirical and definitive therapy (10% vs. 31%, p = 0.042; 0% vs. 19%, p = 0.004, respectively). Multivariate analysis revealed that the broad-spectrum antibiotics for definitive therapy, such as antipseudomonal penicillin, were associated with treatment failure in patients with MSSA bacteremia (OR = 17, p = 0.003). Hence, narrow-spectrum antibiotics should be prescribed for MSSA bacteremia as alternatives during a cefazolin shortage. |
format | Online Article Text |
id | pubmed-8532967 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-85329672021-10-23 Impact of Cefazolin Shortage on Clinical Outcomes of Adult Patients with Bacteremia Caused by Methicillin-Susceptible Staphylococcus aureus in a Tertiary Care University Hospital Uda, Atsushi Onuma, Kenichiro Shigemura, Katsumi Kitagawa, Koichi Yan, Yonmin Osawa, Kayo Yano, Ikuko Miyara, Takayuki Antibiotics (Basel) Article Cefazolin is an essential antibiotic used for treating bacteremia; in particular, it is recommended as a first-line agent for infections caused by methicillin-susceptible Staphylococcus aureus (MSSA). In March 2019, problems with a major antibiotic supplier caused a critical shortage of cefazolin in Japan; however, the impact of the cefazolin shortage on clinical outcomes remains unknown. This study aimed to evaluate the effect of the cefazolin shortage in patients with MSSA bacteremia. Data from 75 patients were compared between the pre-shortage (March 2018–January 2019, n = 39) and post-shortage (March 2019–January 2020, n = 36) periods. There were no significant differences in the demographic characteristics between the two groups, and the cefazolin shortage did not worsen clinical outcomes such as adverse drug reactions, treatment failure, and 30-day mortality. In the post-shortage group, ampicillin/sulbactam and benzylpenicillin were more frequently administered as alternative antibiotics for empirical and definitive therapy (10% vs. 31%, p = 0.042; 0% vs. 19%, p = 0.004, respectively). Multivariate analysis revealed that the broad-spectrum antibiotics for definitive therapy, such as antipseudomonal penicillin, were associated with treatment failure in patients with MSSA bacteremia (OR = 17, p = 0.003). Hence, narrow-spectrum antibiotics should be prescribed for MSSA bacteremia as alternatives during a cefazolin shortage. MDPI 2021-10-14 /pmc/articles/PMC8532967/ /pubmed/34680827 http://dx.doi.org/10.3390/antibiotics10101247 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Uda, Atsushi Onuma, Kenichiro Shigemura, Katsumi Kitagawa, Koichi Yan, Yonmin Osawa, Kayo Yano, Ikuko Miyara, Takayuki Impact of Cefazolin Shortage on Clinical Outcomes of Adult Patients with Bacteremia Caused by Methicillin-Susceptible Staphylococcus aureus in a Tertiary Care University Hospital |
title | Impact of Cefazolin Shortage on Clinical Outcomes of Adult Patients with Bacteremia Caused by Methicillin-Susceptible Staphylococcus aureus in a Tertiary Care University Hospital |
title_full | Impact of Cefazolin Shortage on Clinical Outcomes of Adult Patients with Bacteremia Caused by Methicillin-Susceptible Staphylococcus aureus in a Tertiary Care University Hospital |
title_fullStr | Impact of Cefazolin Shortage on Clinical Outcomes of Adult Patients with Bacteremia Caused by Methicillin-Susceptible Staphylococcus aureus in a Tertiary Care University Hospital |
title_full_unstemmed | Impact of Cefazolin Shortage on Clinical Outcomes of Adult Patients with Bacteremia Caused by Methicillin-Susceptible Staphylococcus aureus in a Tertiary Care University Hospital |
title_short | Impact of Cefazolin Shortage on Clinical Outcomes of Adult Patients with Bacteremia Caused by Methicillin-Susceptible Staphylococcus aureus in a Tertiary Care University Hospital |
title_sort | impact of cefazolin shortage on clinical outcomes of adult patients with bacteremia caused by methicillin-susceptible staphylococcus aureus in a tertiary care university hospital |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532967/ https://www.ncbi.nlm.nih.gov/pubmed/34680827 http://dx.doi.org/10.3390/antibiotics10101247 |
work_keys_str_mv | AT udaatsushi impactofcefazolinshortageonclinicaloutcomesofadultpatientswithbacteremiacausedbymethicillinsusceptiblestaphylococcusaureusinatertiarycareuniversityhospital AT onumakenichiro impactofcefazolinshortageonclinicaloutcomesofadultpatientswithbacteremiacausedbymethicillinsusceptiblestaphylococcusaureusinatertiarycareuniversityhospital AT shigemurakatsumi impactofcefazolinshortageonclinicaloutcomesofadultpatientswithbacteremiacausedbymethicillinsusceptiblestaphylococcusaureusinatertiarycareuniversityhospital AT kitagawakoichi impactofcefazolinshortageonclinicaloutcomesofadultpatientswithbacteremiacausedbymethicillinsusceptiblestaphylococcusaureusinatertiarycareuniversityhospital AT yanyonmin impactofcefazolinshortageonclinicaloutcomesofadultpatientswithbacteremiacausedbymethicillinsusceptiblestaphylococcusaureusinatertiarycareuniversityhospital AT osawakayo impactofcefazolinshortageonclinicaloutcomesofadultpatientswithbacteremiacausedbymethicillinsusceptiblestaphylococcusaureusinatertiarycareuniversityhospital AT yanoikuko impactofcefazolinshortageonclinicaloutcomesofadultpatientswithbacteremiacausedbymethicillinsusceptiblestaphylococcusaureusinatertiarycareuniversityhospital AT miyaratakayuki impactofcefazolinshortageonclinicaloutcomesofadultpatientswithbacteremiacausedbymethicillinsusceptiblestaphylococcusaureusinatertiarycareuniversityhospital |